Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 8, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Smith Downgraded (ABBV) to Hold on, Nov 8th, 2022
Justin Smith of Societe Generale, Downgraded "AbbVie Inc." (ABBV) to Hold on, Nov 8th, 2022.
Justin has made no other calls on ABBV in the last 4 months.
There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 5 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
- Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022
- Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022
- Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $135 on, Friday, July 15th, 2022
These are the ratings of the 7 analyists that currently disagree with Justin
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $178 on, Monday, October 31st, 2022
- David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
- Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022
Contributing Sources